Hepatitis C virus reinfection after successful treatment with direct-acting antiviral therapy in a large population-based cohort
Direct-acting antiviral therapies (DAA) are an important tool for hepatitis C virus (HCV) elimination. However, reinfection among people who inject drugs (PWID) may hamper elimination targets. Therefore, we estimated HCV reinfection rates among DAA-treated individuals, including PWID.
Published in 2019 by Carmen Rossi et al, Journal of Hepotology Nov 2018